Fatigue and fatigue-related symptoms in patients treated for different causes of hypothyroidism

European Journal of Endocrinology

Volumn 167, Issue 6, 2012, Pages 809-815

  Louwerens, Marloes ^a   Appelhof, Bente C ^b   Verloop, Herman ^a   Medici, Marco ^c   Peeters, Robin P ^c   Visser, Theo J ^c   Boelen, Anita ^b   Fliers, Eric ^b   Smit, Johannes W A ^a   Dekkers, Olaf M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; THYROID HORMONE; THYROTROPIN RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFERENTIATED THYROID CANCER; FATIGUE; FATIGUE RELATED SYMPTOM; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; IDIOPATHIC HYPOPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL FATIGUE INVENTORY; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; THYROIDECTOMY; TSHR GENE;

ADULT; ALLELES; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; GENOTYPE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, THYROTROPIN; THYROID NEOPLASMS;

EID: 84869026413     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0501     Document Type: Article

References (41)

1. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R &Dayan CM. Psychologicalwell-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clinical Endocrinology 2002 57 577-585. (doi:10.1046/j.1365-2265.2002.01654.x)
2. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JG & Wiersinga WM. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. European Journal of Endocrinology 2005 153 747-753. (doi:10.1530/eje.1.02025)
3. Brokken LJ, Bakker O, Wiersinga WM & Prummel MF. Functional thyrotropin receptor expression in the pituitary folliculo-stellate cell line TtT/GF. Experimental and Clinical Endocrinology & Diabetes 2005 113 13-20. (doi:10.1055/s-2004-830516)
4. Bahn RS. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy. Journal of Endocrinological Investigation 2004 27 216-220.
5. Crisp MS, Lane C, Halliwell M, Wynford-Thomas D & Ludgate M. Thyrotropin receptor transcripts in human adipose tissue. Journal of Clinical Endocrinology and Metabolism 1997 82 2003-2005.
6. Drvota V, Janson A, Norman C, Sylven C, Haggblad J, Bronnegard M&Marcus C. Evidence for the presence of functional thyrotropin receptor incardiac muscle. Biochemical and Biophysical Research Communications 1995 211 426-431. (doi:10.1006/bbrc.1995.1831)
7. Morimura T, Tsunekawa K, Kasahara T, Seki K, Ogiwara T, Mori M & Murakami M. Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin. Endocrinology 2005 146 2077-2084. (doi:10.1210/en.2004-1432)
8. Murakami M, Kamiya Y, Morimura T, Araki O, Imamura M, Ogiwara T, Mizuma H & Mori M. Thyrotropin receptors in brown adipose tissue: thyrotropin stimulates type II iodothyronine deiodinase and uncoupling protein-1 in brown adipocytes. Endocrinology 2001 142 1195-1201. (doi:10.1210/en.142.3.1195)
9. Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV & Fenzi G. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 1993 342 337-338. (doi:10.1016/0140-6736(93)91475- 2)
10. Francis T, Burch HB, Cai WY, Lukes Y, Peele M, Carr FE, Wartofsky L & Burman KD. Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid 1991 1 223-228. (doi:10.1089/thy.1991.1.223)
11. Bockmann J, Winter C, Wittkowski W, Kreutz MR & Bockers TM. Cloning and expression of a brain-derived TSH receptor. Biochemical and Biophysical Research Communications 1997 238 173-178. (doi:10.1006/bbrc.1997.7268)
12. Crisanti P, Omri B, Hughes E, Meduri G, Hery C, Clauser E, Jacquemin C & Saunier B. The expression of thyrotropin receptor in the brain. Endocrinology 2001 142 812-822. (doi:10.1210/en.142.2.812)
13. Grommen SV, Geysens S, Darras VM& De Groef B. Chicken folliculostellate cells express thyrotropin receptor mRNA. Domestic Animal Endocrinology 2009 37 236-242. (doi:10.1016/j.domaniend.2009.06.003)
14. Labudova O, Cairns N, Koeck T, Kitzmueller E, Rink H & Lubec G. Thyroid stimulating hormone-receptor overexpression in brain of patients with Down syndrome and Alzheimer's disease. Life Sciences 1999 64 1037-1044. (doi:10.1016/S0024-3205(99)00030-2)
15. Saunier B, Pierre M, Jacquemin C & Courtin F. Evidence for cAMP-independent thyrotropin effects on astroglial cells. European Journal of Biochemistry 1993 218 1091-1094. (doi:10.1111/j.1432-1033.1993.tb18469.x)
16. Hanon EA, Lincoln GA, Fustin JM, Dardente H, Masson-Pevet M, Morgan PJ & Hazlerigg DG. Ancestral TSH mechanism signals summer in a photoperiodic mammal. Current Biology 2008 18 1147-1152. (doi:10.1016/j.cub.2008.06.076)
17. Yasuo S, Yoshimura T, Ebihara S & Korf HW. Photoperiodic control of TSH-β expression in the mammalian pars tuberalis has different impacts on the induction and suppression of the hypothalamohypopysial gonadal axis. Journal of Neuroendocrinology 2010 22 43-50. (doi:10.1111/j.1365-2826.2009.01936.x)
18. Peeters RP, van der Deure WM & Visser TJ. Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. European Journal of Endocrinology 2006 155 655-662. (doi:10.1530/eje.1.02279)
19. Hansen PS, van der Deure WM, Peeters RP, Iachine I, Fenger M, Sorensen TI, Kyvik KO, Visser TJ & Hegedus L. The impact of a TSH receptor gene polymorphism on thyroid-related phenotypes in a healthy Danish twin population. Clinical Endocrinology 2007 66 827-832. (doi:10.1111/j.1365-2265.2007.02820.x)
20. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG & Visser TJ. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels inhealthy subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 2880-2888. (doi:10.1210/jc. 2002-021592)
21. 4levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clinical Endocrinology 2008 68 175-181. (doi:10.1111/j.1365-2265.2007.03016.x)
22. Heemstra KA, van der Deure WM, Peeters RP, Hamdy NA, Stokkel MP, Corssmit EP, Romijn JA, Visser TJ & Smit JW. Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma. European Journal of Endocrinology 2008 159 69-76. (doi:10.1530/EJE-08-0038)
23. Peeters RP, van der Deure WM, van den Beld AW, van Toor H, Lamberts SW, Janssen JA, Uitterlinden AG & Visser TJ. The Asp727Glu polymorphism in the TSH receptor is associated with insulin resistance in healthy elderly men. Clinical Endocrinology 2007 66 808-815. (doi:10.1111/j.1365-2265.2007.02817.x)
24. Procopciuc LM, Hazi GM, Caracostea G, Dragotoiu G, Iordache G, Olteanu I & Stamatian F. Correlation between the TSHRc-Asp727Glu polymorphismand plasma thyroid stimulating hormone levels in Romanian preeclamptic women. Gynecological Endocrinology 2011 27 225-231. (doi:10.3109/09513590.2010.526658)
25. Bianco AC, Salvatore D, Gereben B, Berry MJ & Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 2002 23 38-89. (doi:10.1210/er.23.1.38)
26. Appelhof BC, Peeters RP, Wiersinga WM, Visser TJ, Wekking EM, Huyser J, Schene AH, Tijssen JG, Hoogendijk WJ & Fliers E. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′-triiodothyronine therapy. Journal of Clinical Endocrinology and Metabolism 2005 90 6296-6299. (doi:10.1210/jc.2005-0451)
27. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC &Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Journal of Clinical Epidemiology 2008 61 344-349. (doi:10.1016/j.jclinepi.2007.11.008)
28. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HC & Wiersinga WM. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. Journal of Clinical Endocrinology and Metabolism 2005 90 2666-2674. (doi:10.1210/jc.2004-2111)
29. Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA & Pereira AM. Quality of life in treated adult craniopharyngioma patients. European Journal of Endocrinology 2006 154 483-489. (doi:10.1530/eje.1.02114)
30. Smets EM, Garssen B, Cull A & De Haes JC. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. British Journal of Cancer 1996 73 241-245. (doi:10.1038/bjc.1996. 42)
31. Miller SA, Dykes DD & Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988 16 1215. (doi:10.1093/nar/16.3.1215)
32. 2). Methods in Enzymology 1982 84 272-303. (doi:10.1016/0076-6879(82)84024-X)
33. Barendregt PJ, Visser MR, Smets EM, Tulen JH, van den Meiracker AH, Boomsma F & Markusse HM. Fatigue in primary Sjogren's syndrome. Annals of the Rheumatic Diseases 1998 57 291-295. (doi:10.1136/ard.57.5.291)
34. Ott J, Promberger R, Kober F, Neuhold N, Tea M, Huber JC &Hermann M. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 2011 21 161-167. (doi:10.1089/thy.2010. 0191)
35. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB & Morris JC. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. Journal of Clinical Endocrinology and Metabolism 1999 84 3328-3335. (doi:10.1210/jc.84.9. 3328)
36. Nogueira CR, Kopp P, Arseven OK, Santos CL, Jameson JL &Medeiros-Neto G. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil. Thyroid 1999 9 1063-1068. (doi:10.1089/thy.1999.9.1063)
37. Sykiotis GP, Neumann S, Georgopoulos NA, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Paschke R, Vagenakis AG & Papavassiliou AG. Functional significance of the thyrotropin receptor germline polymorphism D727E. Biochemical and Biophysical Research Communications 2003 301 1051-1056. (doi:10.1016/S0006-291X(03)00071-8)
38. Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL, Wiersinga WM, Swaab DF, Visser TJ &Fliers E. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 2005 90 4322-4334. (doi:10.1210/jc.2004-2567)
39. Fliers E, Unmehopa UA & Alkemade A. Functional neuroanatomy of thyroid hormone feedback in the human hypothalamus and pituitary gland. Molecular and Cellular Endocrinology 2006 251 1-8. (doi:10.1016/j.mce.2006.03. 042)
40. Kohrle J. Local activation and inactivation of thyroid hormones: the deiodinase family. Molecular and Cellular Endocrinology 1999 151 103-119. (doi:10.1016/S0303-7207(99)00040-4)
41. Dugbartey AT. Neurocognitive aspects of hypothyroidism. Archives of Internal Medicine 1998 158 1413-1418. (doi:10.1001/archinte.158.13.1413)